We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Smart Watches Could Identify Parkinson’s Disease Years before Symptoms Appear

By HospiMedica International staff writers
Posted on 10 Jul 2023

Parkinson's disease impacts brain cells known as dopaminergic neurons, predominantly located in an area called the substantia nigra. More...

This condition leads to motor symptoms such as tremors, stiffness or rigidity, and slowed movements. Unfortunately, by the time these classic symptoms of Parkinson's become apparent, facilitating clinical diagnosis, over half of the substantia nigra cells have already died. Consequently, there's an urgent need for cost-effective, reliable, and readily available methods to detect early changes, thereby permitting intervention before the disease inflicts extensive brain damage. Now, new research has revealed that smartwatches could potentially identify Parkinson's up to seven years prior to the onset of characteristic symptoms and clinical diagnosis.

A study led by scientists at Cardiff University (Wales, UK) analyzed data gathered by smartwatches over a week, focusing on the speed of participants' movements. The researchers examined data derived from 103,712 UK Biobank participants who wore medical-grade smartwatches for a week between 2013 and 2016. These devices continuously measured average acceleration, or movement speed, throughout the seven-day span. The team compared data from a subset of participants already diagnosed with Parkinson's disease to another group diagnosed up to seven years after the smartwatch data collection. They also compared these groups to age and sex-matched healthy individuals.

The researchers discovered that they could accurately predict, using artificial intelligence (AI), who would eventually develop Parkinson's disease. Not only could they differentiate these participants from the healthy controls, but they also demonstrated that the AI could identify individuals in the general population who would later develop Parkinson's. This method was found to be more precise than any other risk factor or recognized early disease sign in predicting Parkinson's development. The machine learning model was also capable of predicting the time to diagnosis. According to the researchers, this could serve as a novel screening tool for Parkinson's disease, facilitating detection at much earlier stages than current methods permit.

“Smartwatch data is easily accessible and low-cost. As of 2020, around 30 percent of the UK population wear smart watches. By using this type of data, we would potentially be able to identify individuals in the very early stages of Parkinson’s disease within the general population,” said study leader Dr. Cynthia Sandor, Emerging Leader at the UK Dementia Research Institute at Cardiff University.

“We have shown here that a single week of data captured can predict events up to seven years in the future. With these results we could develop a valuable screening tool to aid in the early detection of Parkinson’s. This has implications both for research, in improving recruitment into clinical trials, and in clinical practice, in allowing patients to access treatments at an earlier stage, in future when such treatments become available,” added Dr. Sandor

Related Links:
Cardiff University 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Warming Cabinet
EC1850BL
New
Cervical Seal
Omni Lok
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.